Drugs / Arista AH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00227084 | Sep 2005 → Oct 2006 | — | University of Oslo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arista AH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00227084 ↗ |
| Modality | Other / unclassified | “microporous polysaccharides used as a powder” NCT00227084 ↗ |
| Route | Topical | “powder applied to the wound area” NCT00227084 ↗ |